WORK Medical Technology Group LTD (WOK)
NASDAQ: WOK · Real-Time Price · USD
1.490
-0.030 (-1.97%)
At close: Feb 17, 2026, 4:00 PM EST
1.460
-0.030 (-2.01%)
After-hours: Feb 17, 2026, 7:53 PM EST
WOK Revenue
In the fiscal year ending September 30, 2025, WORK Medical Technology Group LTD had annual revenue of $9.85M, down -14.41%. WORK Medical Technology Group LTD had revenue of $5.31M in the half year ending September 30, 2025, with 16.48% growth.
Revenue (ttm)
$9.85M
Revenue Growth
-14.41%
P/S Ratio
0.04
Revenue / Employee
$41,381
Employees
238
Market Cap
1.82M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Sep 30, 2025 | 9.85M | -1.66M | -14.41% |
| Sep 30, 2024 | 11.51M | -2.06M | -15.18% |
| Sep 30, 2023 | 13.57M | -6.15M | -31.18% |
| Sep 30, 2022 | 19.71M | -26.15M | -57.02% |
| Sep 30, 2021 | 45.86M | -6.66M | -12.68% |
| Sep 30, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| STRATA Skin Sciences | 30.98M |
| Nuwellis | 8.17M |
| Intelligent Bio Solutions | 3.58M |
| ENvue Medical | 2.69M |
| Catheter Precision | 730.00K |
| Tivic Health Systems | 482.00K |
| Profusa | 75.00K |
WOK News
- 7 weeks ago - WORK Medical Grants East China Exclusive Distribution Rights for AI-Automated Blood Cell Morphology Analyzer, Sets RMB10 Million Sales Target for 2026 - GlobeNewsWire
- 7 weeks ago - WORK Medical Technology Group LTD Subsidiary Obtains Manufacturing Approval for Its AI-Automated Blood Cell Morphology Analyzer - GlobeNewsWire
- 7 weeks ago - WORK Medical Technology Group LTD Announces 1-for-100 Reverse Stock Split Effective December 29, 2025 - GlobeNewsWire
- 3 months ago - WORK Medical Technology Group LTD's Subsidiary Retains a US$114,000 Service Contract from GemPharmatech Corporation - GlobeNewsWire
- 4 months ago - WORK Medical Technology Group LTD Announces US$1 Million Equity Investment in Neologics Bioscience - GlobeNewsWire
- 4 months ago - WORK Medical Technology Group LTD Announces 1-for-100 Reverse Stock Split Effective October 21, 2025 - GlobeNewsWire
- 4 months ago - WORK Medical Technology Group LTD Announces Receipt of Delisting Determination Letter from Nasdaq - GlobeNewsWire
- 4 months ago - WORK Medical Technology Group LTD Granted Additional 180-Day Period to Regain Nasdaq Compliance - GlobeNewsWire